TAYSHA GENE THERAPIES Trademark

Trademark Overview

On Tuesday, June 15, 2021, a trademark application was filed for TAYSHA GENE THERAPIES with the United States Patent and Trademark Office. The USPTO has given the TAYSHA GENE THERAPIES trademark a serial number of 90773805. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2024. This trademark is owned by Taysha Gene Therapies, Inc.. The TAYSHA GENE THERAPIES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and pharmaceutical preparations for use in the treatment of genetic diseases and disorders
taysha gene therapies

General Information

Serial Number90773805
Word MarkTAYSHA GENE THERAPIES
Filing DateTuesday, June 15, 2021
Status700 - REGISTERED
Status DateTuesday, September 10, 2024
Registration Number7502769
Registration DateTuesday, September 10, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements

Goods and ServicesPharmaceuticals and pharmaceutical preparations for use in the treatment of genetic diseases and disorders
NOT AVAILABLE"GENE THERAPIES"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 1, 2021
Primary Code005
First Use Anywhere DateWednesday, December 20, 2023
First Use In Commerce DateWednesday, December 20, 2023

Trademark Owner History

Party NameTaysha Gene Therapies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDallas, TX 75247
Party NameTaysha Gene Therapies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDallas, TX 75247
Party NameTaysha Gene Therapies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDallas, TX 75247

Trademark Events

Event DateEvent Description
Monday, March 7, 2022ASSIGNED TO EXAMINER
Friday, June 18, 2021NEW APPLICATION ENTERED
Wednesday, September 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 8, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, March 8, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 8, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 8, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, March 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 8, 2022SOU EXTENSION 1 GRANTED
Tuesday, November 8, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 8, 2022SOU EXTENSION 1 FILED
Tuesday, April 18, 2023SOU EXTENSION 2 GRANTED
Thursday, November 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 18, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 18, 2023SOU EXTENSION 2 FILED
Tuesday, November 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 7, 2023SOU EXTENSION 3 FILED
Tuesday, November 7, 2023SOU EXTENSION 3 GRANTED
Thursday, November 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 5, 2024USE AMENDMENT FILED
Thursday, January 25, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 5, 2024TEAS STATEMENT OF USE RECEIVED
Friday, January 26, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 13, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 10, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Saturday, February 10, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, February 16, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Related Keywords

therapies gene taysha diseases disorders genetic treatment pharmaceutical preparations pharmaceuticals